Tony Radford

Non-Executive Director / Genetic Signatures

Dr Anthony Radford was a member of the CSIRO team that invented the QuantiFERON method for cellular immune based diagnostics.

He later joined AMRAD in pharmaceutical research and was head of development in 2000 when he left to co-found the Cellestis Limited which listed on the ASX in 2001. Dr Radford was chief executive of Cellestis until its acquisition by QIAGEN NV in 2011.

Lists and Charts

Roles

2015

Non-Executive Director

Genetic Signatures

Year started and most recent title

Total Shareholder Return as at 02/12/24

Rank	Company	1 Yr	5 Yr
365^th	Toubani Resources	38.46%	0%
366^th	US Masters Residential Property Fund	38.26%	-13.57%
367^th	Genetic Signatures	38.23%	-8.88%
368^th	Westfield Innaloo	38.02%	21.57%
369^th	Westfield Whitford City	38.02%	21.57%

View Full List

1767 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Share Transactions

Person Activity

	REMUNERATION UPDATE: Non-Executive Director, Genetic Signatures	13 Nov 2020
	NEW ROLE: Non-Executive Director, Genetic Signatures	03 Nov 2020

Related Information

Access to our data for Tony Radford is only available to paid subscribers with Data & Insights access.

Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.

Tony Radford is linked to 1 organisation which is included in 1 list - Public Companies - non WA.

To see the data you will need to Subscribe.